27th October 2021 | Pharma Updates
Govt in conversation with Cadila for its vaccine pricing
Cadila’s vaccine shot would be over Covishield and Covaxin rate.
Cipla launches an anti-viral nasal spray
The anti-viral spray can destroy the disease-causing viruses and bacteria in the nose itself.
NPPA fixes ceiling prices of 12 antidiabetic generic drugs
The price control includes glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6/tablet and at Rs 5.72/tablet for 2 mg strength.
BD opens CoE at CMC, Vellore
This Centre of Excellence will serve as the National Reference Centre for clinical diagnostics applications, wherein physicians, hematologists, lab experts from all over India can collaborate to discuss standardisation and the best practices in clinical flow cytometry.
Glenmark launches Type 2 Diabetes drug in India
Glenmark received a nod for the drug from the DCGI for manufacturing and marketing in September 2021.
Ayurvedic medicines in India's Kerala schools to prevent Covid
Indian Medical Association and health experts have opposed the distribution of Arsenicum Album among school kids.
Cochrane India to push effective medicines
As many medicines were used without research during Covid times. So, a few scientists and medical doctors have come together to form a group which is known as Cochrane India.